News from mabvax therapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 10, 2014, 08:00 ET

MabVax Therapeutics Announces Stock Ticker Symbol Change to MBVX

 MabVax Therapeutics Holdings, Inc. ("MabVax"), a clinical stage oncology drug development company, announced today that FINRA has approved a...

Sep 25, 2014, 09:00 ET

MabVax Therapeutics Receives Orphan Drug Designation for Therapeutic Vaccine to Treat Childhood Cancer Neuroblastoma

 MabVax Therapeutics Holdings, Inc. (OTCQB: TELKD), a clinical stage oncology drug development company, announced today that the U.S. Food and...

Sep 10, 2014, 09:00 ET

MabVax Therapeutics Enters Agreements with Memorial Sloan Kettering Cancer Center and Juno Therapeutics for Development of Anti-Cancer Therapeutics

 MabVax Therapeutics Holdings, Inc. (OTCQB: TELK), a clinical stage oncology drug development company, announced today it has entered into...

Sep 09, 2014, 09:00 ET

MabVax Therapeutics Receives Stockholder Approval for Name Change and Reverse Stock Split Resulting From Merger With Telik

MabVax Therapeutics Holdings, Inc. (OTCQB: TELK), a publicly-traded clinical stage cancer immunotherapy company, announced today that stockholders...

Jul 09, 2014, 09:30 ET

MabVax Therapeutics Raises $3 Million In Common Stock Financing And An Additional $1.5 Million Upon Exercise Of Series C-1 Warrants

 MabVax Therapeutics, Inc., a privately held cancer immunotherapy company has closed a $3 Million common stock financing.  MabVax entered...

May 12, 2014, 16:30 ET

MabVax Therapeutics And Telik Sign Definitive Merger Agreement

 MabVax Therapeutics, Inc., a privately held cancer immunotherapy company and Telik, Inc. (Nasdaq: TELK), aclinical stage oncology drug...

Sep 24, 2013, 07:00 ET

MabVax Therapeutics Receives $1,750,000 Small Business Innovation Research Contract Award From The National Cancer Institute To Support Development of Novel Pancreatic Cancer Diagnostic Imaging Agent

MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of innovative vaccine and antibody...

Dec 18, 2012, 07:00 ET

MabVax Therapeutics Receives SBIR Program Award From The National Cancer Institute To Manufacture Clinical Supplies For Phase 2 Neuroblastoma Trial

MabVax Therapeutics Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies...

Nov 20, 2012, 07:00 ET

MabVax Therapeutics Closes $5.25 Million Financing with Numoda Capital Innovations, Burrill Capital Fund IV, and RTP Venture Fund

MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of proprietary immunotherapies to...

Apr 11, 2011, 07:00 ET

MabVax Therapeutics Receives $1.8 Million in a Phase 2 Small Business Innovation Research Program Award From the National Cancer Institute

MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies...

Aug 17, 2010, 08:00 ET

MabVax Therapeutics Receives Small Business Innovation Research Program Award from the National Cancer Institute

MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies...

Aug 10, 2010, 08:00 ET

MabVax Therapeutics Receives $1.1 Million Phase 2 Small Business Technology Transfer Program Award From The National Cancer Institute

MabVax Therapeutics Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies...

Jul 22, 2010, 08:00 ET

MabVax Therapeutics Initiates Phase II Clinical Trial of Vaccine to Prevent Recurrent Sarcoma

MabVax Therapeutics Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies...

Aug 12, 2008, 01:00 ET
A F FARMER BOYS FOOD LOGO FARMER BOYS FOOD LOGO

Farmer Boys Food, Inc. Logo. (PRNewsFoto/Farmer Boys Food, Inc.)[RD]
 RIVERSIDE, CA UNITED STATES
 08/12/2008

MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research

SAN DIEGO, Aug. 12 /PRNewswire/ -- MabVax Therapeutics, Inc., a privately held immunotherapeutics discovery and development company focused on...